MetroNIDAZOLE 1.3 % Vaginal Gel
RxNorm 1608253
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1608253 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: metroNIDAZOLE 1.3 % Vaginal Gel.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Metronidazole 0.013 mg/MG Vaginal Gel
(Atom ID: 12349460)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
MetroNIDAZOLE 0.013 mg/MG Vaginal Gel
(Atom ID: 6841462)
PSNPrescribable
Prescribable Name (PSN):
MetroNIDAZOLE 1.3 % Vaginal Gel
(Atom ID: 6840483)
SYPrescribable
Synonym (SY):
Metronidazole 1.3 % Vaginal Gel
(Atom ID: 6840484)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
MetroNIDAZOLE 1.3 % Vaginal Gel
(Atom ID: 6841457)
Patient Education
Metronidazole Vaginal
Metronidazole is used to treat vaginal infections such as bacterial vaginosis (an infection caused from too much of certain bacteria in the vagina). Metronidazole is in a class of medications called nitroimidazole antimicrobials. It works by stopping the growth of bacteria.
[Learn More]
* Please review the disclaimer below.